EvidenceSynthesisManager,HTA

**Job purpose:** Reporting to the Evidence Strategy & Operations Lead, this role operates across therapeutic areas to deliver payer‑focused evidence generation, drive HEOR activities for priority assets. The role has a strong HTA focus and will drive HTA submission projects, prioritising evidence packages and dossier development to meet local HTA and reimbursement requirements; coordinate evidence generation, modelling and stakeholder engagement; and provide HTA‑specific scientific and strategic input to secure favourable access outcomes. **Key Responsibilities:** _**Evidence synthesis & health economics**_ * Lead health economics projects to generate high quality and timely data to support the access of prioritised brands to the Japan market, including leading and executing evidence synthesis activities: systematic literature reviews (SLRs), targeted literature reviews (TLRs) and meta-analyses to support HTA, economic models and payer evidence needs. * Responsible for the development and delivery of Japan health technology assessment (HTA) submissions including development and agreement of strategy, liaison with internal and external senior stakeholders and the reimbursement bodies. * Input into pricing decisions for brands to ensure that cost effectiveness is appropriately considered in decision making. * Collaborate with Asset Leads in Japan and Global Real-World Evidence & Health Outcomes Research (RWE-HO), local cross-functional teams, including Government Affairs & Market Access (GAMA), regulatory and development to ensure payer/ value evidence are developed with a full understanding of the requirements of Japan health system/ policy landscape. _**Capability building & stakeholder engagement **_ * Build relationships with HTA bodies, payer advisors, clinical experts, and academic institutions to ensure external relevance and scientific credibility. * Monitor healthcare policy, HTA trends, and competitive landscape to inform proactive evidence planning. * Drive